Amid concerns that the pharmaceutical industry abuses the U.S. patent system, a new paper suggests one way to crack down on the problem — amend a little-known method for correcting mistakes that ...

Patent litigation remains prolific in the life sciences industry as ensuring protection becomes more challenging and complex due to the involvement of technologies. Some issues plaguing patent owners ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Expiring patents can be a catalyst for M&A in the life sciences industry as pharmaceutical and biotechnology companies seek to maintain revenue streams and competitive advantages. In this edition of ...

Glucagon-like peptide-1 (GLP-1) was first discovered in the 1980s as a regulator of glucose levels. Further research led to the creation of a stabilized GLP-1RA called semaglutide, the active ...

Growing consensus is emerging that artificial intelligence (AI) may assist biotechnology and life sciences companies to draft ...